Evorpacept (ALX148) is a high affinity CD47-blocking fusion protein with an inactive human immunoglobulin Fc region designed to enhance the activity of other anti-neoplastic therapies, with minimal additional toxicity.
CAS Number:
[2484949-51-9]
Target:
Immunology/Inflammation
* VAT and and shipping costs not included. Errors and price changes excepted